Elliot Colburn

The Department is committed to supporting all schools in their preparations for the introduction of relationships education (RE), relationships and sex education (RSE) and health education from September 2020.

In July 2018, as part of the consultation on the draft regulations and statutory guidance, the Department published a draft impact assessment, which set out the assessment the Department had made of the impact of the requirement to teach compulsory RE and RSE on independent and maintained schools. The assessment was made in line with requirements set out in the Small Business, Enterprise and Employment Act 2015, and responses to the consultation helped finalise the regulations, statutory guidance and impact assessment. The Government response can be found here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/780768/Government_Response_to_RSE_Consultation.pdf.

The Department is investing in a central support package to support all schools to increase the confidence and quality of their teaching practice. We are currently developing a new online service featuring training materials, case studies and support to access resources. This will be available from April 2020 with additional content added through the summer term, covering all of the teaching requirements in the statutory guidance. The implementation guide will also be provided to all schools as part of this service, and training offers will be available for schools that need additional support.

Since 5 October 2015, large retailers in England have been required by law to charge a minimum of 5p for single-use carrier bags (SUCBs) and to report on the amount they sell each year. The data for the year 2020-2021 will be published in the summer.

The full datasets for each reporting year are on Gov.UK and can be accessed here: https://www.gov.uk/government/publications/carrier-bag-charge-summary-of-data-in-england.

The obligation for supermarkets to charge for SUCBs supplied with online deliveries (online grocery delivery bags) was temporarily removed in response to the first Covid-lockdown. These changes were only temporary, from 21 March 2020 to 21 September 2020. This exemption was made as a precautionary measure and in order to allow retailers time to adapt their delivery systems. As well as the charge exemption, the obligation to report during this time period was waived. The charge for these bags was reinstated in September 2020 along with the reporting requirement. Therefore the dataset for the year 2020-2021, will not include data from this period on bags used for online deliveries.

Defra does not hold records on which household and waste recycling centres (HWRCs) charge for the disposal of waste. The Controlled Waste Regulations 2012 set out charging arrangements for different categories of waste, including waste delivered to HWRCs. Charges made by local authorities to dispose of DIY waste vary and some do not charge for this service.

In our Resources and Waste Strategy we committed to ensuring that charging arrangements in the Controlled Waste Regulations are clear, especially in relation to waste arising from small scale DIY construction activities carried out by ordinary householders with no specialist skills, which the government has been clear should not be charged for. We will review the Household Waste Recycling Centre services and the Controlled Waste Regulations and, subject to consultation, will amend them to ensure they remain fit for purpose, charges are fairly applied, and that services are accessible, support high levels of recycling and deliver value for money.

It is established good practice for local authorities to scan any cat or dog found on the streets so that the owner can be informed. Cats Protection reports that 80% of councils in England routinely scan cats involved in accidents.

Additionally, Highways England has clear guidelines for contractors to follow when they find a deceased cat or dog. This process is designed with owners in mind, giving them the best chance of being informed of the incident to allow closure. The process is laid out in the Network Management Manual and in 2015 the necessary arrangements were made in all Highways England’s contracts to collect and identify cats and dogs killed on the strategic road network and to contact their owners.

The end of the transition period will present new opportunities for managing our own Pet Travel rules and welfare arrangements for all pets, including cats. We are listening to the concerns of stakeholders around future requirements and the Government is developing a range of options to ensure there are robust controls on disease and animal welfare whilst allowing pet owners to continue to be able to travel to and from the EU with the minimum of disruption.

I recognise the important role that pets play in providing companionship to owners of all ages in this country. Recent events have highlighted how much we, as a nation of animal lovers, value this companionship, as we experienced restrictions in social contact and saw an increased demand for pets, including cats, both for purchase and rehoming. I agree with the All-Party Parliamentary Group on Cats that cats can help alleviate loneliness.

Defra officials will engage with the Department of Health and Social Care in relation to any actions they wish to take relating to those aspects and recommendations in the report covering mental health issues and associated NHS costs.

The Animal and Plant Health Agency (APHA) only holds records of pregnant dogs where other non-compliances were found at time of interception on entry to Great Britain. APHA does not record details of compliant animals which were pregnant at time of interception.

According to APHA records, eight dogs were seized in 2020 under Council Regulation (EC) no 1/2005, Annex I, FITNESS FOR TRANSPORT, Chapter I, 2(c) ‘pregnant females for whom 90% or more of the expected gestation period has already passed’. An additional 11 pregnant bitches not in their last 10% were seized in 2020.

The Government shares the public's high regard for animal welfare, including the welfare of dogs and cats. The UK is a leader when it comes to the protection of animals, and we intend to go even further now that we have left the EU.

The Government is appalled by the prospect of dogs and cats being consumed. However, it is already illegal to sell dog and cat meat for human consumption and we have seen no evidence that dog or cat meat is being sold or consumed in this country. The organisation behind the recent campaign to ban the consumption of dog and cat meat in this country acknowledged this point.

We are confident that our current position sends a clear message that the slaughter and consumption of dogs and cats will never be acceptable. The Foreign and Commonwealth Office raises concerns about the welfare of animals with other governments at every suitable opportunity, and we are pleased to hear that authorities in China are proposing to ban the consumption of dog and cat meat.

Defra takes the illegal importation of pets seriously. It is an abhorrent trade which causes suffering to animals and puts the health of pets and people in the UK at risk.

In terms of the regulation and enforcement of non-commercial pet travel movements, we operate one of the most rigorous and robust pet travel checking regimes in the world. All pet animals entering Great Britain on approved routes under the EU Pet Travel Scheme undergo documentary and identity checks, and the Animal and Plant Health Agency (APHA) works collaboratively with Border Force and other operational partners at ports, airports and inland, sharing intelligence to enforce the Pet Travel Scheme, disrupt illegal imports and seize non-compliant animals. Any animals found to be non-compliant with the Pet Travel Scheme rules may be refused entry or detained until compliant.

Regarding changing levels of pet imports (both commercial and non-commercial) during the COVID-19 lockdown, APHA has confirmed that during the initial period of lockdown (March-April 2020), we saw a reduction of pet movements. This increased to relatively routine figures as COVID-19 movement restrictions were eased. On non-commercial pet travel, 14,718 pets were moved into Great Britain in March 2020. Numbers of movements then fell to 1,834 in April 2020 and rose to 4,810 in May 2020. On the commercial imports of cats, dogs and ferrets under the Balai Directive, 2,506 animals were imported into the UK in March 2020, falling to 1,114 in April 2020. Numbers of commercial imports are steadily rising again and now sit at 6,741 for the month of August 2020.

The end of the Transition Period may open up new opportunities for managing our own commercial and non-commercial import and pet travel arrangements. The Government will be considering our pet travel and import arrangements (including for puppies and kittens) as part of cracking down on puppy smuggling in line with our manifesto commitment.

The Government takes the welfare of all animals seriously, and that is why we have committed to cracking down on puppy smuggling. Looking to the future, leaving the EU after the transition period may open up new opportunities for managing our own pet travel arrangements, including ensuring there are robust controls on disease and animal welfare.

Defra takes the issue of puppy smuggling seriously. It is an abhorrent trade which causes suffering to puppies and puts the health of pets and people in the UK at risk. We continue to work closely with Dogs Trust to address this issue and understand the evolving trade.

The Government is developing a range of options to strengthen our efforts to tackle puppy smuggling, taking into consideration the recommendations of Dogs Trust and other stakeholders. As part of this work, we have conducted a renewed rabies risk assessment and have commissioned assessments to understand the risks posed by tapeworms, as well as ticks and tick-borne disease. The results of these will be used to inform our future policy options.

The Environment Agency (EA) as the regulatory body for the site will receive the returns from the operator for January 2020. These will be submitted to the EA in April 2020 as part of the quarterly reporting process. This information is then reviewed and validated by the EA. Following this process the EA will be able to confirm the number of invalid emissions, if any.

The Environment Agency (EA) regulates the Energy Recovery Facility (Erf) in Beddington Lane, Sutton through an Environmental Permit under the Environmental Permitting Regulations 2010. The permit has strict conditions relating to acceptable levels of emissions of substances. The ErF operator (Viridor) is required to continuously and periodically monitor the emissions from the Erf stacks and submit the monitoring data quarterly to the EA.

The EA assesses all data submitted including breaches in emission limits for trends and requires the operator to investigate issues and take actions to rectify them.

The quarterly monitoring data that covers January 2020 is due to be submitted to the EA before end of April 2020. The EA have not received any notifications for breaches in emission limits during January 2020.

The Environment Agency (EA) regulates the Energy Recovery Facility (Erf) in Beddington Lane, Sutton through an Environmental Permit under the Environmental Permitting Regulations 2010. The permit has strict conditions relating to acceptable levels of emissions of substances. The ErF operator (Viridor) is required to continuously and periodically monitor the emissions from the Erf stacks and submit the monitoring data quarterly to the EA.

The EA assesses all data submitted including breaches in emission limits for trends and requires the operator to investigate issues and take actions to rectify them.

The quarterly monitoring data that covers January 2020 is due to be submitted to the EA before end of April 2020. The EA have not received any notifications for breaches in emission limits during January 2020.

Air quality is generally improving in the UK, as set out in the annual National Statistics report at the following URL: https://www.gov.uk/government/statistics/air-quality-statistics.

There are 171 automatic national monitoring stations producing hourly air quality measurements in the UK operated by the Environment Agency on behalf of Defra. Near real-time measurements from these sites and further data tools can be found on the UK-AIR website (https://uk-air.defra.gov.uk).

There are no automatic national monitoring stations in Carshalton and Wallington constituency. However, the London Borough of Sutton also assesses air quality using three automatic monitors within the constituency boundary: two are industrial monitoring stations at Beddington Lane, and the other site is a roadside site in central Wallington. Near real-time measurements from these sites can be found on the London Air website which is managed by King’s College London (http://londonair.org.uk). Air quality is improving at all three sites, with only the Wallington site providing an exceedance of the annual mean limit value for nitrogen dioxide (NO₂) in 2019 (based on provisional data).

The Borough also uses 15 passive monitors to measure NO₂ within the constituency boundaries; measurements are made available through Annual Status Reports (https://www.sutton.gov.uk/info/200497/pollution/1232/air_pollution/3). Only two exceedances of the annual mean limit value for NO₂ were observed in 2018 (at Rosehill Roundabout and London Road, Hackbridge) with levels at most sites either showing a lower or similar value compared with 2017 levels.

No assessment has been made of trends in the number of fires being reported at waste incinerator sites since 2015.

In England all incinerators that are regulated by the Environment Agency (such as energy from waste plants that burn municipal waste) are required to have a management system which identifies and minimises the risk of pollution due to accidents, which will include fires. All new incinerators must also have an approved fire prevention plan before they are allowed to start operating.

No assessment has been made of trends in the number of fires being reported at waste incinerator sites since 2015.

In England all incinerators that are regulated by the Environment Agency (such as energy from waste plants that burn municipal waste) are required to have a management system which identifies and minimises the risk of pollution due to accidents, which will include fires. All new incinerators must also have an approved fire prevention plan before they are allowed to start operating.

Defra has not made such an assessment. Residual waste should be treated in accordance with the waste hierarchy.

To assist decision makers, the department published information on the mechanical biological treatment of waste in 2013. This can be found on the GOV.UK website at: www.gov.uk/government/publications/mechanical-biological-treatment-of-municipal-solid-waste.

Information on energy from waste (incineration with energy recovery) was published in 2014 at: www.gov.uk/government/publications/energy-from-waste-a-guide-to-the-debate.

In May the Government agreed a £1.6 billion funding and finance package with Transport for London (TfL) to enable them to continue operating essential services, transporting passengers safely and protecting staff during the pandemic.

Transport in London is devolved to the Mayor and there are difficult choices to be made to ensure that he is minimising the call on the government funding package in the interest of the taxpayer.

Government is currently undertaking a review of TfL’s finances which will consider TfL’s revenues and costs over the next five years.

Government works with all key partners across the country, including Transport for London (TfL) and London Boroughs, to ensure consideration is given to transport connectivity from the earliest stages of the development of proposals.

In addition, as part of the Extraordinary Funding and Finance Agreement, agreed to by the Mayor of London and the Deputy Mayor for Transport, TfL are pushing forward with an ambitious Active Travel Plan to promote cycling and walking, including new segregated cycle lanes, closures of roads to traffic and pavement extensions across London, which is supported by £55 million from the funding package.

The Croydon Area Remodelling Scheme is part of the wider Brighton Mainline Upgrade Programme. If the Programme goes ahead, it will deliver additional capacity and performance improvements through the Croydon and Selhurst area and across the southeast. The origin and destination of new services has not yet been determined, but could include additional services to those stations listed in the Hon Gentleman’s question.

No assessment has been made of the merits of making platform extensions at Hackbridge. As part of its ongoing programme of network planning, the Department has received no indication from Network Rail that platform extensions at Hackbridge would be a priority for enhancement funding at this time.

Ministers and officials at the Department for Transport meet regularly with representatives of the Mayor’s office and Transport for London to discuss a wide range of topics. During the COVID 19 outbreak these meetings have necessarily increased, and are often held daily. Due to the frequency of these meetings, it would be impractical to provide a definitive list of attendees and apologies for all of these meetings.

As part of the funding package agreed with the Mayor of London to allow Transport for London to continue operating essential services in London during the COVID 19 outbreak, the Mayor agreed to reinstate the congestion charge. The decision to temporarily increase the congestion charge was taken by the Mayor and will be considered as part of the upcoming Government lead review of TfL’s financial position.

Powers to tackle vehicle idling are available to Local Authorities, including the ability to issue Fixed Penalty Notices where necessary. However, this issue will not be solved simply through fining motorists. Local Authorities should utilise a range of methods to encourage motorists to change their behaviour, including public information campaigns. Better technology can play a part in addressing idling, such as stop-start technology and low- or -zero-emission vehicles. In particular the growth in Electric Vehicle sales is expected to assist in lowering emissions.

The Access for All programme provides accessibility improvements over and above those required by the rail industry. Carshalton Beeches was nominated for the programme but not selected as it was difficult to justify its inclusion ahead of other busier stations with a higher industry priority.

However, I am committed to improving access at all stations, and will continue to seek further opportunities, and funding, to make more improvements.

I have not made an assessment of Southern rail services departing Wallington at this time. However, please note that, on the whole, since January 2019, we have recorded On Time figures of 71%, with cancellations recording 4.1%

The Department monitors each train operator’s overall performance against its performance benchmarks regularly and there are clear actions set out in the franchise agreement should performance drop below what is expected.

From February 2019 to February 2020 for Govia Thameslink Railway, the Moving Annual Average (MAA) Passenger Performance Measure (PPM), was 85.2%. This is a 3.1% improvement on the previous year.

From February 2019 to February 2020 for Govia Thameslink Railway (GTR), the operator of Southern services, the Moving Annual Average Passenger Performance Measure (PPM), which measures trains arriving at their destination within 5 minutes of their scheduled arrival time, was 85.2%. This is a 3.1 point improvement on the previous year. Southern is the best performing of GTR’s brands with a PPM figure of 86.1% for the most recent four-week period. There is still room for improvement and the Government is committed to investing around £48 billion in maintaining and upgrading the rail network in the period from 2019 to 2024, focused on increasing reliability and punctuality for passengers.

For these stations, the annual averages for trains calling within one minute of the scheduled time are: 74.0% of services at Wallington, 70.0% of services at Hackbridge, 86.6% of services at Carshalton and 78.1% of services at Carshalton Beeches. The Department monitors each train operator’s overall performance against its performance benchmarks (cancellations, delay minutes and capacity) regularly and there are clear actions set out in the franchise agreement should performance drop below what is expected.

The Department monitors each train operator’s overall performance against its performance benchmarks, and this includes the capacity regime, which measures the number of short formations during the peaks. Govia Thameslink Railway is currently meeting the required levels. However should it fail to do so there are clear actions set out in the franchise agreement in order to remedy any underperformance.

The Department monitors each train operator’s overall performance against its performance benchmarks (cancellations, delay minutes and capacity) regularly and there are clear actions set out in the franchise agreement should performance drop below what is expected. The Department is committed to working with Govia Thameslink Railway (GTR) in driving punctuality higher and, in partnership with Network Rail and other industry partners, GTR is focused on continuous improvement through the joint On Time Railway initiative.

The Getting It Right First Time (GIRFT) speciality report on renal medicine, published September 2021, recommended that all renal centres provide a minimum of 20% of patients with dialysis services at home within 12 months.

NHS England and NHS Improvement’s Renal Services Transformation Plan (RSTP) has established 11 regional clinical networks to meet this recommendation. Of 51 renal centres, 16 units have met or exceeded this minimum level, with several centres achieving more than 30% of patients receiving dialysis at home. NHS England and NHS Improvement have asked renal networks to ensure units continue to develop home therapies and increase levels of dialysis at home. Providers, integrated care systems and regional commissioners will monitor progress via the UK Renal Registry and NHS England Renal datasets.

The GIRFT report set a deadline for all centres to establish the required staffing model by September 2022. NHS England and NHS Improvement are encouraging clinicians and centres to consider the GIRFT recommendations in their work and the individual sites will evaluate how best to implement them.

We have not made a specific assessment. Information on such costs is not collected in the format requested.

By 26 October 2021, 100,305 care home staff were reported to have received a COVID-19 booster vaccine or approximately 18% of all reported care home staff.

We have funded an additional 1,500 undergraduate medical school places each year for domestic students in England – a 25% increase over three years. This expansion was completed in September 2020 and has delivered five new medical schools in England. In addition, we have temporarily lifted the cap on medical school places for students who completed A-Levels in 2020 and in 2021 and who had an offer from a university in England to study medicine, subject to their grades. There are currently no plans to further increase the number of places.

All care home residents are eligible for a COVID-19 booster vaccination at three months since their second dose was administered. Booster doses have been delivered at over 99% of older adult care homes in England. Roving vaccination teams will continue to visit care homes to deliver additional doses required. Where there are care homes currently experiencing COVID-19 outbreaks, booked visits by vaccination teams will take place when it is safe for all to do so.

All care home residents are eligible for a COVID-19 booster vaccination at three months since their second dose was administered. Booster doses have been delivered at over 99% of older adult care homes in England. Roving vaccination teams will continue to visit care homes to deliver additional doses required. Where there are care homes currently experiencing COVID-19 outbreaks, booked visits by vaccination teams will take place when it is safe for all to do so.

In view of the rapid approval of Project Orbis medicines, NHS England and NHS Improvement and the National Institute for Health and Care Excellence (NICE) have developed an interim process to support patient access to medicines between Project Orbis licensing approval and publication of NICE guidance. It is anticipated that this will only be required in the short term. Consideration is given to:

- whether there is expected to be three months or longer between regulatory approval by the Medicines and Healthcare products Regulatory Agency and publication by NICE of its final draft guidance;

- if there are any direct competitors expected to go through the NICE technology appraisal process within the next six months;

- if the treatment will make a fundamental, positive change to the existing treatment pathway; and

- whether the company will offer the medicine or treatment on a cost neutral basis.

NHS England and NHS Improvement and NICE are continuing to work with the manufacturer to explore options for interim access to Trodelvy.

In view of the rapid approval of Project Orbis medicines, NHS England and NHS Improvement and the National Institute for Health and Care Excellence (NICE) have developed an interim process to support patient access to medicines between Project Orbis licensing approval and publication of NICE guidance. It is anticipated that this will only be required in the short term. Consideration is given to:

- whether there is expected to be three months or longer between regulatory approval by the Medicines and Healthcare products Regulatory Agency and publication by NICE of its final draft guidance;

- if there are any direct competitors expected to go through the NICE technology appraisal process within the next six months;

- if the treatment will make a fundamental, positive change to the existing treatment pathway; and

- whether the company will offer the medicine or treatment on a cost neutral basis.

NHS England and NHS Improvement and NICE are continuing to work with the manufacturer to explore options for interim access to Trodelvy.

No estimate has been made.

The independent review of National Health Service hospital food was published on the 20 October 2020 and is available at the following link:

https://www.gov.uk/government/publications/independent-review-of-nhs-hospital-food

It includes recommendations to improve hospital food for patients, staff and visitors, including the religious requirements of patients, visitors and staff. An expert group is being assembled to implement the recommendations of this report, with a sub-group to look at how food is best provided to patients given their medical conditions, personal or cultural preferences and religious requirements. This sub-group will include representatives from religious organisations. While Kosher foods are not mentioned specifically, it is part of wider cultural and diversity work.

NHS England and NHS Improvement continue to monitor the monthly data published by NHS Digital on the prescribing of anti-psychotic medication for people diagnosed with dementia. They have regular conversations with regional clinical network leads and local services to understand the patterns in prescribing and potential reasons for these trends.

The Department’s cancer strategy is incorporated as part of the NHS Long Term Plan. Prostate cancer priorities are included as part of the Long Term Plan such as the introduction of a faster diagnosis standard. This includes the delivery of optimal timed diagnostic pathways for specific cancers, including prostate cancer.

Personalised stratified follow up pathways for prostate cancer are being launched across England to empower patients to take control of their care. Prostate cancer is one of the first three cancers for which this is being implemented.

Treatment options for prostate cancer are always expanding and in February 2021, NHS England and NHS Improvement’s specialised commissioning team announced that it would make available external beam radiotherapy to treat hormone sensitive, low volume prostate cancer. In addition to external beam radiotherapy, the National Institute of Health and Care Excellence will review several new treatment options for prostate cancer in the next 12 months.

Following treatment for prostate cancer, patients move to a Personalised Stratified Follow-Up pathway that suits their needs and ensures they can get rapid access to clinical support where they are worried that their cancer may have recurred. This stratified follow-up approach was established in all trusts for prostate cancer in 2020. In response to the pandemic, the NHS also made available a range of ‘COVID-19 friendly’ treatments, offering benefits such as fewer hospital visits or a reduced impact on the patient’s immune system. This includes targeted hormone therapies such as enzalutamide for prostate cancer treatment.

In 2019, the United Kingdom National Screening Committee (UK NSC) commissioned a systematic review to look at the issue of breast density. The review found that breast density is related to risk of breast cancer. However, breast density measurements are not yet robust or repeatable enough, there is no ‘gold standard’ test to validate breast density measurements. For these reasons that the UK NSC recommended that additional screening with ultrasound after a negative mammography screening in women with dense breasts should not be introduced. More robust evidence is needed before risk stratification can be considered within the breast screening programme.

NHS England and NHS Improvement published guidance entitled ‘COVID-19 restoration of community health services for children and young people: second phase of NHS response in the community health restoration’ on 3 June 2020 and updated this on 31 July 2020. This makes clear that community services, including therapies such as speech and language therapy, occupational therapy and physiotherapy, must be prioritised for children and young people with special educational needs and disabilities aged up to 25 years old and who have an Education Health and Care Plan in place or who are going through an assessment for one. These services fall under the category of ‘continue essential services’.

Research is underway in the Prospective Trial of Digital Breast Tomosynthesis, carried out by Kings College Hospital NHS Trust in breast screening. This trial involves 100,000 women participating in screening to assess whether tomosynthesis is a useful addition to the routine breast screening programme. The United Kingdom National Screening Committee will review the results of the research expected to be published in 2024.

Tomosynthesis has been approved for use in the National Health Service breast screening programme as an optional extra tool in the assessment of screen detected soft tissue breast abnormalities, following the primary screen.

In addressing the cancer screening backlog resulting from COVID-19, NHS England and NHS Improvement have made prioritisation decisions based upon expert clinical advice and engagement with Public Health England (PHE). On the basis of a United Kingdom National Screening Committee evidence review, PHE has advised that breast density measurements are not yet accurate enough to be safely used in routine breast screening. There is also no readily available breast density measurement for women currently in the programme. It is therefore not advisable or feasible to prioritise invitations for breast screening by breast tissue density.

There is currently no published evidence in large scale prospective trials that Artificial intelligence (AI) would be equivalent or better than the current model of having two independent human mammogram readers. AI continues to generate huge amounts of interest for its potential role in the NHS. There is interest in AI for breast screening, where it could replace a human reader of mammograms.

The United Kingdom National Screening Committee (UK NSC) and Public Health England have developed interim guidance for AI developers to help consider key metrics required that would assist the UK NSC to make a recommendation on the use of AI. Both are working with the NHS Accelerated Access Collaborative who are funding a large study in 2021 to understand whether AI can be a useful support to the programme. More information is available at the following link: https://www.england.nhs.uk/aac/

More information about AI and screening can be found at the following link; https://phescreening.blog.gov.uk/2021/02/02/advice-for-nhs-breast-screening-services-on-the-use-of-ai/

National Health Service screening programmes do not hold waiting lists, therefore there is no published waiting time data. Eligible patients are invited to participate in NHS screening programmes at intervals according to the specific programme.

Data sources used by for cancer treatment include cancer waiting times data which give month by month figures on activity, referrals and waiting times, as well as management information which can provide a week to week view of activity and the current scale of the waiting list. Hospital Episode Statistics, and the secondary uses service are used alongside specific sources of information such as the Radiotherapy Dataset or the Diagnostic Imaging Dataset. Data are considered by geography, provider trust, tumour pathway and treatment modality to pinpoint areas for further action.

From March, local systems will be expected to carry out local plans formed as part of the Cancer Services Recovery Plan and continue the progress that has already been made.

The Cancer Recovery Plan aims to restore urgent referrals at least to pre-pandemic levels, to reduce the number of people waiting over 62 days from urgent referral and ensure sufficient capacity to meet demand. The latest published data for November 2020 showed urgent referrals 2% above pre-pandemic levels, the number of people waiting over 62 days 24% above pre-pandemic levels and the number of people starting a first cancer treatment within 31 days at 95% of pre-pandemic levels.

In August 2020, the National Health Service announced a £160 million initiative to extend access to ‘COVID-friendly’ cancer treatments, in October, issued £150 million in funding to expand diagnostic capacity. A further £325 million funding of diagnostics equipment was announced in November’s Spending Review and cancer patients will continue to be prioritised within the NHS and will benefit from the additional £1 billion to begin tackling the elective backlog. Departmental officials regularly engage with their counterparts at HM Treasury regarding upcoming fiscal events.

The Cancer Recovery Plan aims to restore urgent referrals at least to pre-pandemic levels, to reduce the number of people waiting over 62 days from urgent referral and ensure sufficient capacity to meet demand. The latest published data for November 2020 showed urgent referrals 2% above pre-pandemic levels, the number of people waiting over 62 days 24% above pre-pandemic levels and the number of people starting a first cancer treatment within 31 days at 95% of pre-pandemic levels.

In August 2020, the National Health Service announced a £160 million initiative to extend access to ‘COVID-friendly’ cancer treatments, in October, issued £150 million in funding to expand diagnostic capacity. A further £325 million funding of diagnostics equipment was announced in November’s Spending Review and cancer patients will continue to be prioritised within the NHS and will benefit from the additional £1 billion to begin tackling the elective backlog. Departmental officials regularly engage with their counterparts at HM Treasury regarding upcoming fiscal events.

The Government response to the consultation has been delayed due to the COVID-19 pandemic. Following the announcement of the National Institute for Health Protection in August, we are also considering the best future arrangements for the wide range of Public Health England’s non-health protection functions that are vital to support health improvement, prevention and delivery of health services and we will be setting out further details of our approach in due course.

‘Future in Mind’, published by the Department and NHS England in 2015, recommended that children and young people’s mental health services move away from the concept of tiers, in which the system is defined by the services that provide the care, towards models that are defined by how they address patients’ needs.

NHS England has worked with Health Education England to deliver the children and young people’s improving access to psychological therapies programme. It trains new and existing staff working in children and young people’s mental health services and includes evidence-based trauma informed practice.

The National Institute for Health and Care Excellence has made recommendations on the psychological interventions for the prevention and treatment of post-traumatic stress disorder in children and young people in its guideline.

I refer my hon. Friend to the answer I gave to the hon. Member for Strangford (Jim Shannon MP) on 8 October 2020 to Question 99607.

All community services, including rehabilitation, that were previously stopped or partially stopped, should now be fully reinstated. This includes, where needed, home visits for vulnerable adults, subject to appropriate infection control protections.

Prevention, early detection and access to timely treatment are all key to improving eye health. The Government has well-established programmes on reducing smoking and obesity, both long terms risk factors for vision loss.

Free National Health Service sight tests, a vital eye health check, are available to all children, those aged 60 and over, individuals on low incomes or at increased risk of certain eye diseases. Diabetic retinopathy is a common complication of diabetes which can lead to sight loss. The diabetic retinopathy screening programme continues to offer screening to those eligible.

NHS England and NHS Improvement’s national outpatient transformation programme is also looking to improve secondary care ophthalmology outpatient services, to improve patient experience, access to care and outcomes.

The Government’s number one priority for adult social care is for everyone who relies on care to get the care they need throughout the COVID-19 pandemic.

We are committed to bringing forward a plan for social care reform and want to ensure that everyone is treated with dignity and offered the security they deserve, and that nobody needing care is forced to sell their home to pay for it. We want to find long-term solutions for one of the biggest challenges we face as a society. There are complex questions to address and it is important that we give these issues our full consideration in the light of current circumstances.

Sexual and reproductive health services remained open during the pandemic. However physical access remains more limited. Services are maintaining access during this time through scaling up of online services including increasing eligibility through current provision or utilising a neighbours’ service for residents of another local authority. Public Health England has recently launched the National Framework for e-Sexual and Reproductive Healthcare. This new national framework will allow local authorities and service providers to purchase an expanded range of online services including emergency contraception and the contraceptive pill.

Under the Care Act 2014, local authorities have a duty to protect the moveable property (which includes pets) of adults with care and support needs, who are in hospital or are away from home in accommodation such as care homes.

We have provided £3.7 billion to local authorities through un-ringfenced grants so they can address the expenditure pressures they are facing in response to the COVID-19 pandemic.

It is critical that personal protective equipment (PPE) supply reflects equality needs. We are working to understand the different types of PPE that may be needed by those with protected characteristics (as covered under equalities legislation) and how best to distribute that PPE, to address equality for health and social care workers.

The Government recognises that some health and care workers have reported difficulties with the practical use of some PPE. We are committed to understanding the needs of frontline staff, including those for people with different protected characteristics.

We are currently piloting the use of clear masks in social care settings via Local Resilience Forums.

The recall of Randox test kits during the summer has not had any impact on the publication of Care Home visiting guidance.

Considerable progress has been made since the announcement of the Health Infrastructure Plan (HIP) schemes last September, despite coronavirus impacts. A number of the six HIP 1 schemes for new hospitals are approaching early enabling works. HIP 2 schemes have received seed funding and are working up their business cases at pace. We remain committed to, and on target to deliver, on our pledge to build 40 new hospitals.

Work on the development of a new national sexual and reproductive health strategy is underway with the Department working with Public Health England, NHS England and Improvement, local government and other partners. Some initial engagement with stakeholders has already taken place and we are also considering the responses to the Green Paper ‘Advancing our Health’ and the suggestions for priority areas for the new strategy we received through the consultation process. Details of the strategy’s scope, plans for more formal engagement with external organisations, including roundtables, timing of publication and implementation will be announced in due course.

Work on the development of a new national sexual and reproductive health strategy is underway with the Department working with Public Health England, NHS England and Improvement, local government and other partners. Some initial engagement with stakeholders has already taken place and we are also considering the responses to the Green Paper ‘Advancing our Health’ and the suggestions for priority areas for the new strategy we received through the consultation process. Details of the strategy’s scope, plans for more formal engagement with external organisations, including roundtables, timing of publication and implementation will be announced in due course.

Anyone requesting pre-exposure prophylaxis (PrEP) through the Impact Trial must meet the agreed eligibility criteria. A core function of the trial’s Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following link:

https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/

The Impact Trial website includes a map showing the distribution of the 154 clinics level 3 Sexual Health Services participating in the trial at the following link:

www.prepimpacttrial.org.uk

The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for routine commissioning of PrEP from April 2020. NHS England and NHS Improvement have already agreed to fund the on-going costs of drugs for PrEP going forward. We will provide information on how other elements of the programme will be funded and how commissioners will be supported very shortly.

Anyone requesting pre-exposure prophylaxis (PrEP) through the Impact Trial must meet the agreed eligibility criteria. A core function of the trial’s Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following link:

https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/

The Impact Trial website includes a map showing the distribution of the 154 clinics level 3 Sexual Health Services participating in the trial at the following link:

www.prepimpacttrial.org.uk

The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for routine commissioning of PrEP from April 2020. NHS England and NHS Improvement have already agreed to fund the on-going costs of drugs for PrEP going forward. We will provide information on how other elements of the programme will be funded and how commissioners will be supported very shortly.

Epsom and St Helier University Hospitals NHS Trust has a strong track record of providing high quality care to people with suspected or confirmed cases of cancer in a timely manner. Last year, the Trust met all of the waiting time standards we expect for cancer patients, including seeing 97.2% of patients with a suspected cancer within two weeks of their general practitioners (GPs) referral, 99.1% of patients began treatment with 31 days of diagnosis, and 89% of patients began treatment within 62 days of their initial referral.

Epsom and St Helier University Hospitals NHS Trust is working on plans to improve the patient’s experience through their cancer journey. This includes access to a clinical nurse specialist or key worker, and they have recently appointed three Advanced Nurse Practitioners and funding approved to increase number of clinical nurse specialists. The Trust is introducing ‘Living With and Beyond Cancer’ – a new work stream to improve patient experience and care beyond their diagnosis and initial treatment and improving quality of life for those living with cancer. This includes NHS England and NHS Improvement data collection on long term quality of life metrics, stratified follow up pathways, reducing and managing long term outcomes of treatment, and Holistic Needs Assessments.

The Royal Marsden NHS Foundation Trust is a research active organisation, with an academic partnership with The Institute of Cancer Research, and, together, are ranked third in the world for impact of their research. The Royal Marsden is continually looking to improve the treatment options and facilities they offer to patients, including the first linear accelerators (LINAC) in the country and third in the world, which is now treating patients across six tumour types as part of clinical trials.

The Royal Marsden is also the host of RM Partners, the only cancer alliance in England to achieve the 62 day target consistently during 2018/19 and which was awarded a further £10 million in funding from NHS England to continue to improve cancer outcomes for the population across west London.

Epsom and St Helier University Hospitals NHS Trust has a strong track record of providing high quality care to people with suspected or confirmed cases of cancer in a timely manner. Last year, the Trust met all of the waiting time standards we expect for cancer patients, including seeing 97.2% of patients with a suspected cancer within two weeks of their general practitioners (GPs) referral, 99.1% of patients began treatment with 31 days of diagnosis, and 89% of patients began treatment within 62 days of their initial referral.

Epsom and St Helier University Hospitals NHS Trust is working on plans to improve the patient’s experience through their cancer journey. This includes access to a clinical nurse specialist or key worker, and they have recently appointed three Advanced Nurse Practitioners and funding approved to increase number of clinical nurse specialists. The Trust is introducing ‘Living With and Beyond Cancer’ – a new work stream to improve patient experience and care beyond their diagnosis and initial treatment and improving quality of life for those living with cancer. This includes NHS England and NHS Improvement data collection on long term quality of life metrics, stratified follow up pathways, reducing and managing long term outcomes of treatment, and Holistic Needs Assessments.

The Royal Marsden NHS Foundation Trust is a research active organisation, with an academic partnership with The Institute of Cancer Research, and, together, are ranked third in the world for impact of their research. The Royal Marsden is continually looking to improve the treatment options and facilities they offer to patients, including the first linear accelerators (LINAC) in the country and third in the world, which is now treating patients across six tumour types as part of clinical trials.

The Royal Marsden is also the host of RM Partners, the only cancer alliance in England to achieve the 62 day target consistently during 2018/19 and which was awarded a further £10 million in funding from NHS England to continue to improve cancer outcomes for the population across west London.

Both Epsom and St Helier University Hospitals NHS Trust and the Royal Marsden NHS Foundation Trust are committed to improving patient care.

The latest Care Quality Commission (CQC) reports on Epsom and St Helier University Hospitals NHS Trust show for the first time the trust being rated as Good overall. CQC findings indicated improvements and progress in most areas of care.

The CQC continued to rate the Royal Marsden NHS Foundation Trust as outstanding overall.

A consultation is currently underway. The consultation document sets out potential improvements in clinical outcomes for patients under three different options. This includes a new specialist emergency care hospital.

The potential impact of the proposals on accessibility and travel times has been analysed as part of the consultation process and further detail can be found at the following link:

https://improvinghealthcaretogether.org.uk/?s=baseline+travel+analysis

The attached table shows the finished consultant episodes (FCE) and average age in Epsom and St Helier University Hospitals NHS Trust and The Royal Marsden NHS Foundation Trust for the last three years.

A consultation is currently underway. The consultation document sets out potential improvements in clinical outcomes for patients under three different options. This includes a new specialist emergency care hospital.

The potential impact of the proposals on accessibility and travel times has been analysed as part of the consultation process and further detail can be found at the following link:

https://improvinghealthcaretogether.org.uk/?s=baseline+travel+analysis

The attached table shows the finished consultant episodes (FCE) and average age in Epsom and St Helier University Hospitals NHS Trust and The Royal Marsden NHS Foundation Trust for the last three years.

A consultation is currently underway. The consultation document sets out potential improvements in clinical outcomes for patients under three different options. This includes a new specialist emergency care hospital.

The potential impact of the proposals on accessibility and travel times has been analysed as part of the consultation process and further detail can be found at the following link:

https://improvinghealthcaretogether.org.uk/?s=baseline+travel+analysis

The attached table shows the finished consultant episodes (FCE) and average age in Epsom and St Helier University Hospitals NHS Trust and The Royal Marsden NHS Foundation Trust for the last three years.

A consultation is currently underway. The consultation document sets out potential improvements in clinical outcomes for patients under three different options. This includes a new specialist emergency care hospital.

The potential impact of the proposals on accessibility and travel times has been analysed as part of the consultation process and further detail can be found at the following link:

https://improvinghealthcaretogether.org.uk/?s=baseline+travel+analysis

The attached table shows the finished consultant episodes (FCE) and average age in Epsom and St Helier University Hospitals NHS Trust and The Royal Marsden NHS Foundation Trust for the last three years.

The Home Office continues to work with the National Police Chiefs Council (NPCC) to ensure that the data on the Police National Computer (PNC) is necessary, proportionate and accurate, including medical status data. The Home Office has no plans for specific guidance or support to forces at present regarding HIV status beyond that already published in the PNC Manual.

I refer my Hon Friend to the answer I gave to UIN 62648 on 02 July 2020 to the Hon Member for Sevenoaks.

[On 5 November 2019, the Government launched a consultation seeking views on measures to strengthen police powers to tackle unauthorised encampments. The consultation closed on the 5 March. We will announce the outcome of this consultation in due course].

The Home Office does not hold the specific information requested.

The Home Office collects and publishes data on police joiners, broken down by Police Force Area in the annual ‘Police workforce, England and Wales’ statistical bulletin. However, data per London Borough are not available.

Data for the year ending March 2019 are available here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/831666/police-workforce-mar19-tables.ods

Furthermore, the Home Office has also started to publish quarterly updates on ‘Police officer uplift’. The quarterly update contains information on the number of joiners since November 2019 (when these data were first collected). The latest release is available here: https://www.gov.uk/government/statistics/police-officer-uplift-quarterly-update-to-march-2020

The next release of both publications is scheduled for 30 July 2020.

The Government has committed to increasing the number of police officers in England and Wales by 20,000 over the next three years. 6,000 additional officers have been allocated to forces across England and Wales by the end of March 2021 and over 3,000 have already been recruited as at March 2020. The Metropolitan Police Service accounted for 714 of the 3,005 officer uplift (24%), and 25% of all officers in England and Wales.

We are committed to protect communities from the menace of anti-social behaviour. That is why we have enhanced the powers available to tackle anti-social behaviour through the Anti-social Behaviour, Crime and Policing Act 2014.

The powers are flexible, allowing local areas to tailor their response according to the circumstances. They are best-placed to understand their communities’ needs and the most appropriate response.

We keep anti-social behaviour under review through the ASB Strategic Board which brings together key partners.